Loading Events

Upcoming Events

Events Search and Views Navigation

Event Views Navigation

July 2019

American Academy of Neurology 2019 Sports Concussion Conference

July 26 - July 28
JW Marriott Indianapolis, 10 S West St
Indianapolis, IN 46204 United States

The 2019 AAN Sports Concussion Conference is a leading voice in shaping the sport-related concussion conversation for all clinicians and scientists involved in the prevention, diagnosis, and management of sport-related concussion. The conference offers new programming to shape the ever-changing conversation and to prepare physicians to address the challenges of sport-related concussions in their professional lives.

Find out more »

August 2019

ASGCT Career Development Awards

August 1

Sponsor: American Society for Cell and Gene Therapy
Application Due Date: August 1, 2019
Awards and Eligibility: ASGCT will award a $50,000 Career Development Award to support independent transformative pilot studies in gene and cell therapy by ASGCT members, particularly those ideas that would be challenging to fund with normal funding mechanisms.

Find out more »

Cycle 2: Health Services Research Pipeline Grant

August 5

Sponsor: Foundation for Physical Therapy Research
Application Deadline: August 5, 2019
Award and Eligibility: One Health Services Research Pipeline Grant (HSRPG) of $40,000 is to be awarded to support research that examines mechanisms by which patients obtain physical therapy-related health care, how much such care costs, and what outcomes are observed in these patients. Research efforts should focus on the identification of the most effective ways to organize, manage, finance, and deliver high quality physical therapy-related care while potentially reducing medical errors and improving safety for patients.

Find out more »

September 2019

FEPS SIF 2019

September 10 - September 13
Bologna, Italy, Bologna, Italy

The Joint Meeting of the Federation of European Physiological Societies (FEPS) and the Italian Physiological Society (SIF) is preparing a stimulating scientific program which will include 5 plenary lectures, 16 symposia oral communications, and poster sessions.

Find out more »

ISHCSF Hydrocephalus 2019

September 13 - September 16
Hotel Fairmont Vancouver, 900 W Georgia St
Vancouver, British Columbia V6C 2W6 Canada

This annual meeting is the largest worldwide dedicated to research into hydrocephalus and related disorders relevant to all with a dedicated interest in the hydrocephalus and intracranial pressure

Find out more »

October 2019

Cycle 3: Whitehall Foundation Grants-in-Aids

October 1

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: October 1, 2019
Application Due Date: February 15, 2020
Award:  Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

Find out more »

Cycle 3: Whitehall Foundation Research Grants

October 1

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: October 1, 2019
Application Due Date: February 15, 2020
Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.

Find out more »

Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer’s disease and Alzheimer’s related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)

October 9

Sponsor: NIH
LOI Due Date: September 9, 2019
Application Deadline: October 9, 2019
Description:The goal of this initiative is to elucidate the mechanistic links between blood brain barrier (BBB) dysfunction, Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD), and how related comorbidities impact the basic molecular mechanisms of BBB health and function.
Award: Application budgets are limited to $499,000 direct costs/year and need to reflect the actual needs of the proposed project.

Find out more »

Cycle 4: Alzheimer’s Drug Discovery Foundation

October 11

LOI DUE OCTOBER 11, 2019
Drug Discovery Program
The Drug Discovery RFP supports novel drug programs and repurposed/repositioned programs. One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of research.
Program to Accelerate Clinical Trials (PACT)
The goal of this RFP is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer’s disease and related dementias. The average award is up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered.
Biomarkers Development
This RFP seeks to support the development of CSF and neuroimaging biomarkers for multiple contexts of use One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of research.
Prevention Beyond the Pipeline
The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Awards range between $50,000-$100,000 for epidemiological analyses based on scope of research, and can reach up to $3 million for clinical trials based on stage and scope of research.

Find out more »

Society for Neuroscience Annual Meeting 2019

October 19 - October 23

SfN’s 49th annual meeting is the premier venue for neuroscientists to present emerging science, learn from experts, forge collaborations with peers, explore new tools and technologies, and advance careers. Join 30,000 colleagues from more than 80 countries at the world’s largest marketplace of ideas and tools for global neuroscience.

Find out more »

Exploring Human Host-Microbiome Interaction in Health and Disease

October 23 - October 25
Wellcome Genome Campus, Hinxton, Saffron Walden, CB10 1SA United Kingdom

The 8th Exploring Human Host-Microbiome Interactions in Health and Disease meeting will once again bring together leading scientists and clinicians from the fields of microbiology, gastroenterology, neuroscience, cancer and public health to discuss the latest developments in this fast-moving area.

Find out more »

Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)

October 28

Sponsor: NIH Common Fund Program
LOI Due Date: September 28, 2019
Application Deadline: October 28, 2019
Details: The goal of this funding opportunity announcement (FOA) for the Common Fund Program “Illuminating the Druggable Genome” (IDG; https://commonfund.nih.gov/idg/index) is to solicit applications for pilot projects on IDG-eligible understudied proteins (non-olfactory GPCRs, protein kinases, and ion channels) in order to study them beyond what the IDG’s Centers can accomplish and to validate and demonstrate the utility of IDG-generated reagents, data, and approaches.
Award:  Application budgets are limited to $100,000 in direct costs (excluding subcontract F&A) for one year and need to reflect the actual needs of the proposed project.

Find out more »

November 2019

Cycle 3: Prevention Research in Mid-Life Adults (R01)

November 5

Sponsor: National Institutes of Health
Due Date: November 5, 2019 by 5 pm local time of applicant
Award: Money, property, or both to carry out an approved project or activity. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. The maximum grant period is five years.

Find out more »

December 2019

48th Annual AANS/CNS Section on Pediatric Neurological Surgery Meeting

December 5 - December 8
Hyatt Gainey Ranch, 7500 E Doubletree Ranch Rd
Scottsdale, AZ 85258 United States

This year’s speakers at the Annual AANS/CNS Section on Pediatric Neurosurgery meeting include well-known experts who will present their unique, relevant and fascinating knowledge of their respective industries.

 

Find out more »

Rolling Basis: Alzheimer’s Drug Discovery Foundation

December 31

PROPOSALS ACCEPTED ON A ROLLING BASIS
ADDF/NIH
Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities.
Conference Funding
Supports scientific conferences that are relevant to our mission with grants up to $10,000.

Find out more »

January 2020

ANGEL (Advanced Neurotherapeutic Grant of Excellence) Award

January 1, 2020

Sponsor: International Rett Syndrome Foundation (IRSF)
Due Date: Applications accepted on a rolling basis
Award: Up to $600,000 over two years

Find out more »

Cycle 1: Whitehall Foundation Grants-In-Aid

January 1, 2020

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: January 15, 2020
Application Due Date: June 1, 2020
Award: Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

Find out more »

Healthcare Research by Community Physicians

January 1, 2020

Sponsor: Physicans’ Services Incorporated Foundation

Due Date: Applications accepted on a rolling basis

Award: Grants up to $20,000 are available to cover the costs of the data gathering and analysis,
support staff and preparation of reports. Up to an additional $500 will be provided for travel
costs incurred in presenting papers on the results of a community practice study.

 

Find out more »

Cycle 1: Whitehall Foundation Research Grants

January 15, 2020

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: January 15, 2020
Application Due Date: June 1, 2020
Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.

Find out more »

February 2020

Keystone Symposia Conference

February 16, 2020 - February 19, 2020
Eldorado Hotel and Spa, 309 W San Francisco St
Santa Fe, NM 87501 United States

This Keystone conference brings together an interdisciplinary group of new and established scientists to capture this newfound excitement about the CSF. By exchanging discoveries – about its sources (choroid plexus), routes (glymphatics), drainage (lymphatics), and clinical utilities – and by fostering new ideas, collaborations, and training opportunities, this conference aims to coalesce an international community that can propel the CSF field forward.

Find out more »
+ Export Events